CYT003, a TLR9 agonist, in persistent allergic asthma – a randomized placebo‐controlled Phase 2b study

Publisher: John Wiley & Sons Inc

E-ISSN: 1398-9995|70|9|1160-1168

ISSN: 0105-4538

Source: ALLERGY, Vol.70, Iss.9, 2015-09, pp. : 1160-1168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content